Research conducted by the lab of Camille Ehre, PhD, has been featured in multiple news stories across a range of websites. The research, focusing on asthma, COVID-19, and the cytokine IL-13, was initially published in PNAS by Morrison, Ehre, et al under the title “SARS-CoV-2 infection of airway cells causes intense viral and cell shedding, two spreading mechanisms affected by IL-13.” That paper can be found here. The news stories featuring the Ehre lab’s research include:
“Certain asthma patients are less susceptible to severe COVID – here’s why, say UNC-CH researchers,” in WRAL TechWire.
“Q&A: IL-13 protects patients with allergic asthma against effects of SARS-CoV-2 infection,” in Healio.
“Researchers reveal why people with allergic asthma are protected from severe COVID,” in News Medical Life Sciences.
“Omicron variant mild symptoms but highly transmissible and damages lung tissue,” in Medical Laboratory Observer (MLO).
“Having allergic asthma actually protects people from a severe case of COVID-19,” in NBC4.com.
“Having allergic asthma actually protects people from a severe case of COVID-19,” in Fox31.com.
“Does Allergic Asthma Fend Off Severe COVID-19? It’s Complicated,” in Allergic Living.
“The body’s response to allergic asthma also helps protect against COVID-19,” in ScienceNews.